Y90 Radiatioembolization For A Albuquerque
Y90 Radiatioembolization For Albuquerque is a serious and often fatal disease that affects thousands of people each year. While traditional treatments like chemotherapy and surgery can be effective, they can also come with a host of side effects and limitations. In recent years, a new treatment option has emerged – Y90 radioembolization. This minimally invasive procedure uses tiny beads filled with radioactive material to target and kill cancer cells within the liver. In Albuquerque, Y90 radioembolization is quickly becoming a popular choice for patients seeking a less invasive and more effective treatment option for liver cancer.
What is Y90 radioembolization?
Y90 Radiatioembolization For A Albuquerque, also known as selective internal radiation therapy (SIRT), is a minimally invasive treatment option for liver cancer. During the procedure, tiny beads filled with a radioactive material called yttrium-90 (Y90) are injected directly into the blood vessels that supply the liver. The beads then travel to the cancerous tissue within the liver and emit radiation, which destroys the cancer cells.
Unlike traditional radiation therapy, which targets the entire body and can damage healthy tissue, Y90 radioembolization delivers radiation directly to the cancerous tissue within the liver. This targeted approach minimizes damage to healthy tissue and reduces the risk of side effects.
Y90 radioembolization is typically done on an outpatient basis and takes about one to two hours to complete. Most patients can return to their normal activities within a week after the procedure.
Benefits of Y90 radioembolization:
One of the main benefits of Y90 radioembolization is that it is a minimally invasive procedure. Unlike surgery, which requires a large incision and a lengthy recovery period, Y90 radioembolization is done using a small catheter inserted through a tiny incision in the skin. This means that patients experience less pain and have a faster recovery time.
Y90 radioembolization also has fewer side effects than traditional chemotherapy and radiation therapy. Because the radiation is delivered directly to the cancerous tissue within the liver, healthy tissue is spared. This results in fewer side effects like nausea, vomiting, and hair loss.
In addition, Y90 radioembolization has been shown to be effective in treating liver cancer. In a study published in the Journal of Clinical Oncology, researchers found that Y90 radioembolization was more effective than traditional chemotherapy in treating liver cancer that had spread to other parts of the body. The study also found that patients who received Y90 radioembolization had a longer overall survival time than those who received chemotherapy.
Y90 radioembolization in Albuquerque:
In Albuquerque, Y90 radioembolization is becoming an increasingly popular choice for patients with liver cancer. The procedure is offered by several hospitals and clinics in the area, including the University of New Mexico Comprehensive Cancer Center and Lovelace Medical Center.
At the University of New Mexico Comprehensive Cancer Center, patients with liver cancer are evaluated by a team of specialists, including medical oncologists, radiation oncologists, and interventional radiologists. Together, they develop a personalized treatment plan that may include Y90 radioembolization as well as other treatment options like chemotherapy and surgery.
Lovelace Medical Center also offers Y90 radioembolization for the treatment of liver cancer. Their interventional radiologists use the latest technology to ensure that the procedure is safe and effective for each patient.
Is Y90 radioembolization right for you?
If you have been diagnosed with liver cancer, Y90 radioembolization may be a treatment option worth considering. However, it is important to speak with your doctor to determine if it is the right choice for you.
Y90 radioembolization is typically recommended for patients with
Y90 Radiatioembolization For A Albuquerque How Its Work?
Y90 radioembolization, also known as selective internal radiation therapy (SIRT), is a minimally invasive treatment option for liver cancer that works by delivering radiation directly to the cancerous tissue within the liver. This targeted approach minimizes damage to healthy tissue and reduces the risk of side effects.
During the procedure, tiny beads filled with a radioactive material called yttrium-90 (Y90) are injected directly into the blood vessels that supply the liver. The beads are about the size of a grain of sand and are delivered through a small catheter inserted through a tiny incision in the skin.
Once the beads are injected, they travel to the liver and become lodged in the small blood vessels surrounding the cancerous tissue. The Y90 in the beads then emits radiation, which destroys the cancer cells.
The radiation emitted by the Y90 beads has a short half-life, which means that it loses its radioactivity quickly. Within a few days, the radiation levels in the liver have decreased significantly, and the beads are no longer radioactive.
Because the radiation is delivered directly to the cancerous tissue within the liver, healthy tissue is spared. This results in fewer side effects like nausea, vomiting, and hair loss, which are commonly associated with traditional chemotherapy and radiation therapy.
If you want to get amazing benefits by using this link
Conclusion:
Y90 radioembolization is typically done on an outpatient basis and takes about one to two hours to complete. Most patients can return to their normal activities within a week after the procedure.
Y90 radioembolization is not suitable for everyone with liver cancer. It is typically recommended for patients with tumors that cannot be removed by surgery or those who are not candidates for surgery due to other health conditions. It may also be used in combination with other treatments like chemotherapy or radiation therapy.
Before undergoing Y90 radioembolization, patients will undergo a series of tests to determine if they are a suitable candidate for the procedure. This may include imaging tests like CT scans or MRIs to evaluate the size and location of the tumor.
Overall, Y90 radioembolization is a promising treatment option for patients with liver cancer. It offers a targeted approach to treatment that minimizes damage to healthy tissue and reduces the risk of side effects. However, it is important to speak with your doctor to determine if it is the right choice for you.